Search research articles
Contact Us
Filters
Showing results (151-160 of 172) with videos related to
Page
of 18
Sort By:
International Orthopaedics
|
June 5, 2014
Olecranon fractures: factors influencing re-operation
Mark Christopher Snoddy, Maximilian Frank Lang, Thomas J An, et al.
Journal of Medicinal Chemistry
|
October 17, 2022
Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary Angioedema
Rebecca L Davie, Hannah J Edwards, D Michael Evans, et al.
Journal of Medicinal Chemistry
|
October 30, 2025
Correction to "Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary Angioedema"
Rebecca L Davie, Hannah J Edwards, D Michael Evans, et al.
BMC Nephrology
|
November 10, 2016
Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study
Alex R Chang, Michael Evans, Christina Yule, et al.
Frontiers in Nutrition
|
June 29, 2023
Clinical trial of a probiotic and herbal supplement for lung health
Nancy M Wenger, Luhua Qiao, Teodora Nicola, et al.
F1000Research
|
November 13, 2018
Publishing peer review materials
Jeffrey Beck, Kathryn Funk, Melissa Harrison, et al.
Pulmonary Therapy
|
November 18, 2025
Double-Blind Randomized Placebo-Controlled Trial of a Lactobacillus Probiotic Blend in Chronic Obstructive Pulmonary Disease
Teodora Nicola, Nancy M Wenger, Kara Seidman, et al.
Transfusion
|
December 12, 2025
D-Alloantibody Titration Assessment Study: In Search of a Common Antibody Titration Platform-A BEST Collaborative Study
Fatima A Aldarweesh, Rim Abdallah, Ingrid Perez Alvarez, et al.
Oncology
|
August 30, 2017
Adenosquamous Carcinoma of the Esophagus: An NCDB-Based Investigation on Comparative Features and Overall Survival in a Rare Tumor
Michael Evans, Yuan Liu, Chuqing Chen, et al.
The Lancet. Oncology
|
November 3, 2023
Single-dose <sup>177</sup>Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial
Rahul Aggarwal, Stephanie Starzinski, Ivan de Kouchkovsky, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 172) with videos related to
Sort By:
Page
of 18
International Orthopaedics
|
June 5, 2014
Olecranon fractures: factors influencing re-operation
Mark Christopher Snoddy, Maximilian Frank Lang, Thomas J An, et al.
Journal of Medicinal Chemistry
|
October 17, 2022
Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary Angioedema
Rebecca L Davie, Hannah J Edwards, D Michael Evans, et al.
Journal of Medicinal Chemistry
|
October 30, 2025
Correction to "Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary Angioedema"
Rebecca L Davie, Hannah J Edwards, D Michael Evans, et al.
BMC Nephrology
|
November 10, 2016
Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study
Alex R Chang, Michael Evans, Christina Yule, et al.
Frontiers in Nutrition
|
June 29, 2023
Clinical trial of a probiotic and herbal supplement for lung health
Nancy M Wenger, Luhua Qiao, Teodora Nicola, et al.
F1000Research
|
November 13, 2018
Publishing peer review materials
Jeffrey Beck, Kathryn Funk, Melissa Harrison, et al.
Pulmonary Therapy
|
November 18, 2025
Double-Blind Randomized Placebo-Controlled Trial of a Lactobacillus Probiotic Blend in Chronic Obstructive Pulmonary Disease
Teodora Nicola, Nancy M Wenger, Kara Seidman, et al.
Transfusion
|
December 12, 2025
D-Alloantibody Titration Assessment Study: In Search of a Common Antibody Titration Platform-A BEST Collaborative Study
Fatima A Aldarweesh, Rim Abdallah, Ingrid Perez Alvarez, et al.
Oncology
|
August 30, 2017
Adenosquamous Carcinoma of the Esophagus: An NCDB-Based Investigation on Comparative Features and Overall Survival in a Rare Tumor
Michael Evans, Yuan Liu, Chuqing Chen, et al.
The Lancet. Oncology
|
November 3, 2023
Single-dose <sup>177</sup>Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trial
Rahul Aggarwal, Stephanie Starzinski, Ivan de Kouchkovsky, et al.
Page
of 18